Physician profile
Timur Yasin
NPI 1194960658
$956.01
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $98.79 · 2021: $48.21 · 2022: $300 · 2023: $236 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $379.01 | 2019-2024 | Euflexxa |
| Nuvasive, INC. | $146.00 | 2022 | |
| Horizon Therapeutics Plc | $97.08 | 2021-2022 | |
| Djo, LLC | $88.10 | 2019-2023 | Cmf |
| Depuy Synthes Sales INC. | $55.10 | 2022-2024 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $43.39 | 2019-2023 | Zilretta, Iovera |
| Orthofix Medical, INC. | $42.66 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.37 | 2019-2020 | |
| Exeltis, USA INC. | $20.51 | 2022 | |
| Abbott Laboratories | $20.19 | 2019 | |
| Daiichi Sankyo INC. | $19.55 | 2020 | |
| Fidia Pharma USA INC. | $8.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timur Yasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.